Mad in America

JANUARY 29, 2024

If one reads the ADM literature, it is quite apparent that the pharmaceutical industry—with the help of psychiatry—since day one has been involved in a cover up of the dangerousness of these drugs. of the drugs reviewed had two or fewer cases of violence, which is reassuring for most pharmaceuticals. meprobamate) as well.

Healthcare 108

Healthcare Pharmaceuticals Hospitality Aging and mental health 108

Mad in America

JANUARY 9, 2024

Academics even boast that EBM shackles the pharmaceutical industry. In this way, we put everyone else who is injured by the drug in a state of legal jeopardy because companies can claim nothing like happened in our studies – it’s your anecdote against our evidence. Doctors adamantly insist they are not influenced by adverts.

Sleep and mental health 140

Sleep and mental health Legal Healthcare Pharmaceuticals 140

Mad in America

DECEMBER 25, 2023

These drugs have often become the sole treatment for a variety of behavioral health disorders including clinical depression, anxiety disorders, obsessive compulsive disorder, and other approved and off-label uses of these drugs.

Neurotransmitters and mental health 79

Neurotransmitters and mental health Healthcare Aging and mental health Self-awareness 79

Mad in America

FEBRUARY 1, 2025

R egardless of the context and cause, distress is increasingly interpreted and diagnosed as a mental illnesscommonly clinical depression and/or anxiety disorder. This process of medicalisation is now all too often a default response to distress and happens on a large scale.

Aging and mental health 142

Aging and mental health Insurance Mental health policy Pharmaceuticals 142